Literature DB >> 24374813

Serum deprivation elevates the levels of microvesicles with different size distributions and selectively enriched proteins in human myeloma cells in vitro.

Li Sun1, Hong-xiang Wang2, Xiao-jian Zhu1, Pin-hui Wu3, Wei-qun Chen4, Ping Zou1, Qiu-bai Li1, Zhi-chao Chen1.   

Abstract

AIM: To investigate the effects of serum deprivation (SD) on microvesicles (MVs) secreted from human myeloma cells and the implications for disease progression.
METHODS: RPMI 8226, U266, and KM3 human myeloma cells were incubated in medium containing 10% (non-SD) or 1% fetal bovine serum (SD) and MVs were isolated. The levels and size distribution of MVs were analyzed with flow cytometry. The protein profiles of MVs were studied using 2D SDS-PAGE, MALDI-TOF-MS, and Western blotting. NF-κB activation was analyzed using EMSA. Angiogenesis was examined in Eahy926 endothelial cells.
RESULTS: Exposure of RPMI 8226 cells to SD for 24 h did not alter the number of apoptotic cells. However, SD increased the number of MVs from RPMI 8226, U266, and KM3 cells to 2.5-, 4.3-, and 3.8-fold, respectively. The size distribution of SD MVs was also significantly different from that of non-SD MVs. Three proteins ZNF224, SARM, and COBL in SD MVs were found to be up-regulated, which were involved in cell cycle regulation, signal transduction and metabolism, respectively. Co-culture of SD MVs and RPMI 8226 cells increased NF-κB activation in the target RPMI 8226 cells. Furthermore, SD MVs from RPMI 8226 cells significantly increased the microtubule formation capacity of Eahy926 endothelial cells compared with non-SD MVs.
CONCLUSION: SD elevates the levels of microvesicles with different size distribution and selectively enriched proteins in human myeloma cells in vitro. The selectively enriched proteins, especially ZNF224, may play key roles in regulation of myeloma cells, allowing better adaptation to SD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24374813      PMCID: PMC4647891          DOI: 10.1038/aps.2013.166

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  34 in total

Review 1.  Circulating microparticles: pathophysiology and clinical implications.

Authors:  Andrea Piccin; William G Murphy; Owen P Smith
Journal:  Blood Rev       Date:  2006-11-22       Impact factor: 8.250

2.  Intracellular regulation of the production and release of human erythroid-directed lymphokines.

Authors:  N Dainiak; S Sorba
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

3.  Serum starvation: caveat emptor.

Authors:  Sergej Pirkmajer; Alexander V Chibalin
Journal:  Am J Physiol Cell Physiol       Date:  2011-05-25       Impact factor: 4.249

4.  Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells.

Authors:  Yosuke Harada; Mitsugu Kanehira; Yoshiko Fujisawa; Ryo Takata; Taro Shuin; Tsuneharu Miki; Tomoaki Fujioka; Yusuke Nakamura; Toyomasa Katagiri
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

Review 5.  A novel way to spread drug resistance in tumor cells: functional intercellular transfer of P-glycoprotein (ABCB1).

Authors:  Suresh V Ambudkar; Zuben E Sauna; Michael M Gottesman; Gergely Szakacs
Journal:  Trends Pharmacol Sci       Date:  2005-08       Impact factor: 14.819

Review 6.  Actin filament nucleation and elongation factors--structure-function relationships.

Authors:  Roberto Dominguez
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Nov-Dec       Impact factor: 8.250

7.  The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness.

Authors:  A Ginestra; M D La Placa; F Saladino; D Cassarà; H Nagase; M L Vittorelli
Journal:  Anticancer Res       Date:  1998 Sep-Oct       Impact factor: 2.480

8.  ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles.

Authors:  Vandhana Muralidharan-Chari; James Clancy; Carolyn Plou; Maryse Romao; Philippe Chavrier; Graca Raposo; Crislyn D'Souza-Schorey
Journal:  Curr Biol       Date:  2009-11-05       Impact factor: 10.834

9.  Differential stimulation of monocytic cells results in distinct populations of microparticles.

Authors:  M Bernimoulin; E K Waters; M Foy; B M Steele; M Sullivan; H Falet; M T Walsh; N Barteneva; J-G Geng; J H Hartwig; P B Maguire; D D Wagner
Journal:  J Thromb Haemost       Date:  2009-06       Impact factor: 5.824

10.  The influence of the time and temperature of heat treatment on the allergenicity of egg white proteins.

Authors:  Meeyong Shin; Youngshin Han; Kangmo Ahn
Journal:  Allergy Asthma Immunol Res       Date:  2012-11-02       Impact factor: 5.764

View more
  24 in total

1.  Selective surface marker and miRNA profiles of CD34+ blast-derived microvesicles in chronic myelogenous leukemia.

Authors:  Junli Zhang; Aiqi Zhao; Li Sun; Weiqun Chen; Haiming Zhang; Zhichao Chen; Fang Liu
Journal:  Oncol Lett       Date:  2017-06-07       Impact factor: 2.967

2.  Effect of purified fractions from cell culture supernate of high-density pre-B acute lymphoblastic leukemia cells (ALL3) on the growth of ALL3 cells at low density.

Authors:  Sapan J Patel; Costel C Darie; Bayard D Clarkson
Journal:  Electrophoresis       Date:  2016-11-28       Impact factor: 3.535

3.  Studying Unconventional Secretion of Misfolded Proteins in Cultured Cells and Primary Neurons.

Authors:  Juhyung Lee; Yihong Ye
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Extracellular Vesicles: Satellites of Information Transfer in Cancer and Stem Cell Biology.

Authors:  Laura M Desrochers; Marc A Antonyak; Richard A Cerione
Journal:  Dev Cell       Date:  2016-05-23       Impact factor: 12.270

5.  Comparative Analysis of MSC-Derived Exosomes Depending on Cell Culture Media for Regenerative Bioactivity.

Authors:  Jun Yong Kim; Won-Kyu Rhim; Hyo Jeong Seo; Joo Youn Lee; Chun Gwon Park; Dong Keun Han
Journal:  Tissue Eng Regen Med       Date:  2021-05-28       Impact factor: 4.451

Review 6.  Transfer of microRNAs by extracellular membrane microvesicles: a nascent crosstalk model in tumor pathogenesis, especially tumor cell-microenvironment interactions.

Authors:  Li Zhang; C Alexander Valencia; Biao Dong; Meng Chen; Pu-Jun Guan; Ling Pan
Journal:  J Hematol Oncol       Date:  2015-02-22       Impact factor: 17.388

7.  Development of an angiogenesis-promoting microvesicle-alginate-polycaprolactone composite graft for bone tissue engineering applications.

Authors:  Hui Xie; Zhenxing Wang; Liming Zhang; Qian Lei; Aiqi Zhao; Hongxiang Wang; Qiubai Li; Zhichao Chen; WenJie Zhang
Journal:  PeerJ       Date:  2016-05-19       Impact factor: 2.984

Review 8.  Extracellular vesicles swarm the cancer microenvironment: from tumor-stroma communication to drug intervention.

Authors:  F Wendler; R Favicchio; T Simon; C Alifrangis; J Stebbing; G Giamas
Journal:  Oncogene       Date:  2016-08-22       Impact factor: 9.867

9.  Impact of collection, isolation and storage methodology of circulating microvesicles on flow cytometric analysis.

Authors:  Fancong Kong; Liming Zhang; Hongxiang Wang; Guolin Yuan; Anyuan Guo; Qiubai Li; Zhichao Chen
Journal:  Exp Ther Med       Date:  2015-09-25       Impact factor: 2.447

10.  Multiple myeloma dell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation.

Authors:  Bonnie K Arendt; Denise K Walters; Xiaosheng Wu; Renee C Tschumper; Diane F Jelinek
Journal:  Oncotarget       Date:  2014-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.